Doravirine Efficacy Exposure-Response
Analysis at Week 48 and Implications [poster]
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy (IWCPHIVHT) May 26-28, 2015 Washington, DC, USA
Ka Lai Yee,1 Xia Xu,1 Hedy Teppler1
1Merck & Co., Inc., Kenilworth, NJ, USA
